背景胃癌是全球范围内常见的消化道恶性肿瘤之一,严重危害居民的生命和健康。有研究表明肿瘤患者的预后与营养状态具有较高的相关性。近年来越来越多的研究者将预后营养指数(PNI)纳入肿瘤的预后研究中,并通过PNI评价患者的营养状态及预测患者的远期预后。
目的探讨PNI对胃癌肺转移患者预后的评估价值,并建立列线图预测模型。
方法收集2010年7月至2018年7月新疆医科大学第一附属医院诊治的245例胃癌肺转移患者的住院病历及检测报告,分析其临床病理特征,包括年龄、性别、原发灶、组织学分级、T分期、N分期、肺转移类型、肺转移时间、化疗情况、肿瘤直径、血清癌胚抗原(CEA)水平、血清CA199水平、胸腔积液发生情况、脉管癌栓发生情况、原发灶手术情况和术前1周外周血淋巴细胞总数、血清白蛋白水平等,并计算PNI。对患者进行电话或门诊随访,随访截止时间为2019年4月。分析PNI的影响因素及其对胃癌肺转移患者预后的影响,根据患者预后的影响因素建立列线图预测模型。
结果PNI预测胃癌肺转移患者生存结局的最佳截断值为46.1〔依据截断值,将患者分为低PNI值组( n=114)和高PNI值组( n=131)〕,灵敏度为71.7%,特异度为67.8%。多因素Logistic回归分析结果显示,年龄>65岁〔 OR=2.123,95% CI(1.201,3.752)〕、T分期高〔 OR=2.104,95% CI(1.336,3.313)〕、N分期高〔 OR=1.876,95% CI(1.286,2.735)〕、肿瘤直径>5 cm〔 OR=1.839,95% CI(1.054,3.208)〕是导致胃癌肺转移患者PNI低的独立危险因素( P<0.05)。胃癌肺转移患者1年、2年、3年生存率分别为33.3%、15.1%、4.3%。低PNI值组3年生存率为1.0%,低于高PNI值组的11.6%( P=0.001)。多因素Cox回归模型分析结果显示,组织学分级〔 HR=1.414,95% CI(1.059,1.887)〕、肺转移类型〔 HR=1.647,95% CI(1.213,2.237)〕、化疗〔 HR=0.740,95% CI(0.559,0.981)〕、原发灶手术〔 HR=0.649,95% CI(0.475,0.886)〕、PNI〔 HR=0.733,95% CI(0.550,0.978)〕为胃癌肺转移患者预后的独立影响因素( P<0.05)。绘制列线图,纳入多因素Cox回归模型中有统计学意义的影响因素,对胃癌肺转移患者1、2、3年总体生存率进行预测,一致性指数(C-index)为0.755。
结论PNI对胃癌肺转移患者的预后具有重要的预测价值,以此为基础构建的列线图预测模型有利于临床上对患者的预后进行个体化分析。
BackgroundGastric cancer is a common digestive tract cancer worldwide that seriously endangers the life and health of residents. Nutritional status has been reported to be closely related to cancer patients' prognosis, which is assessed by prognostic nutritional index (PNI) in increasing studies to predict long-term prognosis of cancer patients.
ObjectiveTo evaluate the prognostic value of PNI in gastric cancer patients with lung metastasis, and to establish a PNI-based prognostic nomogram.
MethodsParticipants were 245 gastric cancer patients with lung metastasis who were admitted to the First Affiliated Hospital of Xinjiang Medical University from July 2010 to July 2018. By reviewing medical records and test reports, demographic and clinicopathological data were collected, including age, sex, primary lesion, histological grade, T stage, N stage, type of lung metastasis, timing of lung metastasis, chemotherapy status, tumor diameter, prevalence of pleural effusion and intravascular tumor thrombus, primary lesion surgery, serum CEA, serum CA199, number of peripheral lymphocytes and albumin level one week before operation, and calculated PNI. Follow-up data were collected through a telephone or clinic follow-up till April 2019. The influencing factors of PNI and its association with the prognosis were analyzed. A prognostic nomogram was constructed based on potential prognostic factors of gastric cancer patients with lung metastasis.
ResultsThe optimal cut-off value of PNI for predicting 3-year survival in gastric cancer patients with lung metastasis was 46.1 with 71.7% sensitivity and 67.8% specificity. Multivariate Logistic regression analysis showed that age >65 years old〔 OR=2.123, 95% CI (1.201, 3.752) 〕, advanced T stage〔 OR=2.104, 95% CI (1.336, 3.313) 〕, advanced N stage〔 OR=1.876, 95% CI (1.286, 2.735) 〕 and tumor diameter> 5 cm 〔 OR=1.839, 95% CI (1.054, 3.208) 〕were independent risk factors for PNI<46.1 ( P<0.05) . The 1-year, 2-year and 3-year survival rates of gastric cancer patients with lung metastasis were 33.3%, 15.1% and 4.3%, respectively. The 3-year survival rate of low PNI group ( n=114, PNI<46.1) was lower than that of high PNI group ( n=131, PNI>46.1) ( P=0.001) . Multivariate Cox regression analysis showed that histological grade〔 HR=1.414, 95% CI (1.059, 1.887) 〕, type of lung metastasis〔 HR=1.647, 95% CI (1.213, 2.237) 〕, chemotherapy〔 HR=0.740, 95% CI (0.559, 0.981) 〕, primary lesion surgery 〔 HR=0.649, 95% CI (0.475, 0.886) 〕 and PNI〔 HR=0.733, 95% CI (0.550, 0.978) 〕 were independent prognostic factors for gastric cancer patients with lung metastasis ( P<0.05) , and all of which were used to construct the prognostic nomogram to predict the 1-year, 2-year and 3-year overall survival with a C-index of 0.755.
ConclusionPNI may be a major prognostic factor for gastric cancer patients with lung metastasis. And the prognostic nomogram based on PNI is helpful for individualized prognosis analysis.
DILINUER·Aierken, ZHANG H, ABUDUSHATAER·Kadier, et al. Prognostic value of prognostic nutritional index and a prognostic nomogram developed based it for gastric cancer patients with lung metastasis [J] . Chiense General Practice, 2021, 24 (30) : 3863-3869.
迪丽奴尔·艾尔肯,张华,阿布都沙塔尔·卡地尔,等. 预后营养指数在胃癌肺转移患者预后中的意义及列线图预测模型的建立研究[J]. 中国全科医学,2021,24(30):3863-3869.
DOI:10.12114/j.issn.1007-9572.2021.02.019本刊2021年版权归中国全科医学杂志社所有
未经编辑部许可,不得任意转载和摘编
本刊所发表作品仅为作者观点,并不代表编委会和编辑部意见
如有印装质量问题请向本刊发行部调换
本研究将预后营养指数(PNI)引入胃癌肺转移患者的预后研究中,通过构建回归模型,证实了PNI对于胃癌肺转移患者预后的预测价值。此外,本研究将回归分析结果绘制成列线图,将复杂的回归方程转变为简单的可视化图形,使预测模型的预测结果更具可读性,对于临床医务工作者具有较高的实际应用价值。
临床病理特征 | 低PNI值组( n=114) | 高PNI值组( n=131) | χ 2值 | P值 | |
---|---|---|---|---|---|
性别 | 1.216 | 0.270 | |||
男 | 92(80.7) | 98(74.8) | |||
女 | 22(19.3) | 33(25.2) | |||
年龄(岁) | 7.178 | 0.007 | |||
≤65 | 64(56.1) | 95(72.5) | |||
>65 | 50(43.9) | 36(27.5) | |||
原发灶 | 2.188 | 0.335 | |||
上部 | 72(63.2) | 75(57.3) | |||
中部 | 27(23.7) | 42(32.1) | |||
下部 | 15(13.1) | 14(10.6) | |||
组织学分级 | 2.298 | 0.130 | |||
中、高分化 | 43(37.7) | 62(47.3) | |||
低、未分化 | 71(62.3) | 69(52.7) | |||
T分期(期) | 12.809 | 0.005 | |||
T1 | 1(0.9) | 6(4.6) | |||
T2 | 4(3.5) | 11(8.4) | |||
T3 | 14(12.3) | 30(22.9) | |||
T4 | 95(83.3) | 84(64.1) | |||
N分期(期) | 11.542 | 0.009 | |||
N0 | 2(1.8) | 10(7.6) | |||
N1 | 7(6.1) | 16(12.2) | |||
N2 | 53(46.5) | 67(51.1) | |||
N3 | 52(45.6) | 38(29.1) | |||
肺转移类型 | 1.500 | 0.221 | |||
单侧 | 35(30.7) | 50(38.2) | |||
双侧 | 79(69.3) | 81(61.8) | |||
肺转移时间 | 2.284 | 0.131 | |||
同时 | 49(43.0) | 44(33.6) | |||
异时 | 65(57.0) | 87(66.4) | |||
化疗 | 0.235 | 0.628 | |||
无 | 54(47.4) | 58(44.3) | |||
有 | 60(52.6) | 73(55.7) | |||
肿瘤直径(cm) | 6.590 | 0.010 | |||
≤5 | 61(53.5) | 91(69.5) | |||
>5 | 53(46.5) | 40(30.5) | |||
CEA(μg/L) | 1.204 | 0.273 | |||
≤5 | 46(40.4) | 62(47.3) | |||
>5 | 68(59.6) | 69(52.7) | |||
CA199(U/ml) | 0.160 | 0.689 | |||
≤37 | 65(57.0) | 78(59.5) | |||
>37 | 49(43.0) | 53(40.5) | |||
胸腔积液 | 1.038 | 0.308 | |||
无 | 44(38.6) | 59(45.0) | |||
有 | 70(61.4) | 72(55.0) | |||
脉管癌栓 | 0.127 | 0.722 | |||
无 | 83(72.8) | 98(74.8) | |||
有 | 31(27.2) | 33(25.2) | |||
原发灶手术 | 0.094 | 0.759 | |||
无 | 78(68.4) | 92(70.2) | |||
有 | 36(31.6) | 39(29.8) |
注:CEA=癌胚抗原
变量 | 赋值 |
---|---|
年龄(岁) | ≤65=1,>65=2 |
T分期(期) | T1=1,T2=2,T3=3,T4=4 |
N分期(期) | N0=1,N1=2,N2=3,N3=4 |
肿瘤直径(cm) | ≤5=1,>5=2 |
PNI | ≥46.1=0,<46.1=1 |
注:PNI=预后营养指数
变量 | β | SE | Wald χ 2值 | P值 | OR | 95% CI |
---|---|---|---|---|---|---|
年龄 | 0.753 | 0.290 | 6.718 | 0.010 | 2.123 | (1.201,3.752) |
T分期 | 0.744 | 0.232 | 10.299 | 0.001 | 2.104 | (1.336,3.313) |
N分期 | 0.629 | 0.192 | 10.681 | 0.001 | 1.876 | (1.286,2.735) |
肿瘤直径 | 0.609 | 0.284 | 4.606 | 0.032 | 1.839 | (1.054,3.208) |
注:PNI=预后营养指数
Kaplan-Meier curves of high and low PNI groups of gastric cancer patients with lung metastasis变量 | 赋值 |
---|---|
性别 | 男=1,女=2 |
年龄(岁) | ≤65=1,>65=2 |
原发灶 | 上部=1,中部=2,下部=3 |
组织学分级 | 中、高分化=1,低、未分化=2 |
T分期(期) | T1=1,T2=2,T3=3,T4=4 |
N分期(期) | N0=1,N1=2,N2=3,N3=4 |
肺转移类型 | 单侧=1,双侧=2 |
肺转移时间 | 同时=1,异时=2 |
化疗 | 无=1,有=2 |
肿瘤直径(cm) | ≤5=1,>5=2 |
CEA(μg/L) | ≤5=1,>5=2 |
CA199(U/ml) | ≤37=1,>37=2 |
胸腔积液 | 无=1,有=2 |
脉管癌栓 | 无=1,有=2 |
原发灶手术 | 无=1,有=2 |
PNI | ≥46.1=0,<46.1=1 |
指标 | 单因素分析 | 多因素分析 | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P值 | HR | 95% CI | P值 | ||
性别 | 0.855 | (0.609,1.199) | 0.364 | - | - | - | |
年龄 | 1.271 | (0.948,1.705) | 0.109 | - | - | - | |
原发灶 | |||||||
上部 | 1.000 | - | - | - | - | - | |
中部 | 0.868 | (0.630,1.195) | 0.385 | - | - | - | |
下部 | 0.968 | (0.628,1.491) | 0.881 | - | - | - | |
组织学分级 | 1.493 | (1.123,1.984) | 0.006 | 1.414 | (1.059,1.887) | 0.019 | |
T分期 | 1.032 | (0.845,1.260) | 0.757 | - | - | - | |
N分期 | 1.038 | (0.866,1.244) | 0.688 | - | - | - | |
肺转移类型 | 1.672 | (1.237,2.259) | 0.001 | 1.647 | (1.213,2.237) | 0.001 | |
肺转移时间 | 0.723 | (0.504,0.966) | 0.028 | 0.799 | (0.632,1.254) | 0.322 | |
化疗 | 0.697 | (0.526,0.922) | 0.011 | 0.740 | (0.559,0.981) | 0.036 | |
肿瘤直径 | 1.097 | (0.821,1.464) | 0.532 | - | - | - | |
CEA | 1.102 | (0.830,1.462) | 0.503 | - | - | - | |
CA199 | 1.114 | (0.837,1.483) | 0.459 | - | - | - | |
胸腔积液 | 1.292 | (0.972,1.717) | 0.077 | - | - | - | |
脉管癌栓 | 1.204 | (0.878,1.651) | 0.249 | - | - | - | |
原发灶手术 | 0.677 | (0.497,0.922) | 0.013 | 0.649 | (0.475,0.886) | 0.007 | |
PNI | 0.629 | (0.475,0.832) | 0.001 | 0.733 | (0.550,0.978) | 0.035 |
注:-表示无此数据
注:A为1年生存率,B为2年生存率,C为3年生存率
Patient survival calibration curves迪丽奴尔·艾尔肯,张华,阿布都沙塔尔·卡地尔,等.预后营养指数在胃癌肺转移患者预后中的意义及列线图预测模型的建立研究[J].中国全科医学,2021,24(30):3863-3869.[www.chinagp.net]
迪丽奴尔·艾尔肯进行文章的构思与研究的设计,研究的实施与可行性分析,数据收集,论文撰写,并对文章整体负责,监督管理;卡丽比奴尔·艾尔肯进行数据整理;阿布都沙塔尔·卡地尔进行统计学处理;玛依努尔·艾力进行结果的分析与解释、文章的质量控制及审校;迪丽奴尔·艾尔肯、张华进行论文的修订。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。